Clinical Trial Update: OSU6162 as add-on in SSRI/SNRI-resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating OSU6162 as an add-on therapy for SSRI/SNRI-resistant depression; it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Major Depressive Episode
• Treatment-resistant Depression

Drugs mentioned

• OSU6162 (OSU6162)

Snippet

Sponsor: Göteborg University | Conditions: Depression, Depressive Disorder, Treatment-Resistant | Phase 2 | Status: RECRUITING